Alcohol Changes Brain Opioid Peptide Levels That May Drive Addiction and Relapse
Repeated ethanol administration produced both short-term (24-hour) and long-term (2-week) changes in enkephalin and dynorphin levels in the rat mesolimbic reward system, potentially contributing to alcohol addiction and relapse.
Quick Facts
What This Study Found
Repeated ethanol produced both short-term (24h) and persistent (2-week) alterations in enkephalin and dynorphin tissue concentrations in mesolimbic reward regions, providing a neurochemical basis for alcohol craving and relapse.
Key Numbers
How They Did This
Animal study in rats. Repeated ethanol administration followed by measurement of opioid peptide concentrations at 24 hours and 2 weeks post-treatment in nucleus accumbens, striatum, and other mesolimbic regions.
Why This Research Matters
Understanding why alcoholics relapse weeks after their last drink is crucial for treatment. Long-lasting opioid system changes in reward circuits provide a biological explanation and therapeutic target.
The Bigger Picture
Addiction isn't just a choice — it involves persistent neurochemical changes in the brain's reward system. The opioid system changes described here help explain why naltrexone (an opioid blocker) helps treat alcoholism.
What This Study Doesn't Tell Us
Rat model. Ethanol dosing patterns may not match human drinking. Two weeks may not reflect longer-term persistence. Peptide concentration changes don't directly prove functional consequences.
Questions This Raises
- ?Do these opioid changes correlate with alcohol-seeking behavior?
- ?How long do the changes persist beyond 2 weeks?
- ?Could opioid peptide restoration prevent relapse?
Trust & Context
- Key Stat:
- 2 weeks later Opioid peptide changes persisted 2 weeks after stopping ethanol — long-lasting reward circuit alterations that could drive cravings and relapse
- Evidence Grade:
- Preliminary animal evidence with regional brain neurochemistry data at two timepoints, providing insight into persistent addiction-related neural changes.
- Study Age:
- Published in 2000. The opioid system's role in alcohol addiction has been confirmed, supporting use of naltrexone as an FDA-approved alcoholism treatment.
- Original Title:
- Repeated ethanol administration induces short- and long-term changes in enkephalin and dynorphin tissue concentrations in rat brain.
- Published In:
- Alcohol (Fayetteville, N.Y.), 22(3), 165-71 (2000)
- Authors:
- Lindholm, S, Ploj, K(2), Franck, J, Nylander, I
- Database ID:
- RPEP-00601
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Why do alcoholics relapse?
Repeated alcohol use changes opioid peptide levels in the brain's reward system. This study shows these changes persist for at least 2 weeks after stopping, creating a neurochemical drive for cravings and relapse.
Is this why naltrexone helps alcoholism?
Yes. Naltrexone blocks opioid receptors, counteracting the dysfunctional opioid signaling in the reward circuit that this study demonstrates. Understanding these changes validates naltrexone as an evidence-based alcoholism treatment.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00601APA
Lindholm, S; Ploj, K; Franck, J; Nylander, I. (2000). Repeated ethanol administration induces short- and long-term changes in enkephalin and dynorphin tissue concentrations in rat brain.. Alcohol (Fayetteville, N.Y.), 22(3), 165-71.
MLA
Lindholm, S, et al. "Repeated ethanol administration induces short- and long-term changes in enkephalin and dynorphin tissue concentrations in rat brain.." Alcohol (Fayetteville, 2000.
RethinkPeptides
RethinkPeptides Research Database. "Repeated ethanol administration induces short- and long-term..." RPEP-00601. Retrieved from https://rethinkpeptides.com/research/lindholm-2000-repeated-ethanol-administration-induces
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.